港股異動丨好孩子國際(01086.HK)暴漲超38% 股價創近兩個半月新高
格隆匯6月8日丨好孩子國際(01086.HK)自歷史低位反彈,今日大漲逾38%,連續第三日上漲,報0.98港元,股價創近兩個半月新高,總市值16.3億港元。好孩子國際的產品依賴新生兒市場,而我國新生兒數量增速不斷放緩。2019年,中國人口出生率是10.48‰,這是有史以來最低的數值,延續了過去多年來出生率下滑的趨勢。好孩子國際(01086.HK)股價也在過去的兩年最多累跌近89%。上週,在河南省的人大會議上,通過了修改《河南省人口與計劃生育條例》,將其中的第十五條第一款修改為:提倡一對夫妻(含再婚夫妻)生育兩個子女。市場憧憬更高層面的生育政策全面放開並鼓勵生育。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.